Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled date : 2021 - 07 - 29 save search
Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
NVO | $123.43 0.55% 1.4M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
ALNY | News | $146.34 0.81% 64K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
new drug alcohol use disorder fda clearance treatment fda drug application clearance
SCYNEXIS Announces Two Oral Presentations on Pooled Data from the BREXAFEMME (Ibrexafungerp tablets) Phase 3 VANISH Program Demonstrating Consistent Efficacy in the Treatment for Vaginal Yeast Infections at the IDSOG 2021 Virtual Annual Meeting
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
SCYX | $1.4 -0.36% 43K
|
Health Technology
|
| O: 0.68%
H: 3.8%
C: -0.95%
presentation treatment phase 3 injection infections
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -1.17%
ARWR | $22.24 -1.64% 170K
|
Health Technology
|
| O: 1.95%
H: 1.82%
C: -1.98%
disease liver disease treatment fda therapy breakthrough therapy liver designation
Ocular Therapeutix™ Announces First Patient Dosed in U.S.-based Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet Age-Related Macular Degeneration
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
OCUL | News | $5.165 -11.86% 5.1M
|
Health Technology
|
| O: -0.09%
H: 0.09%
C: -3.84%
treatment phase 1 ocular trial macular
Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation
Published: 2021-07-29 (Crawled : 14:15) - globenewswire.com
ALEC | $5.165 1.47% 51K
|
Health Technology
|
| O: 0.07%
H: 2.36%
C: -21.13%
treatment phase 2 dementia results al001
Artificial Intelligence Treatment for Depression
Published: 2021-07-29 (Crawled : 07:00) - brainsway.com
BWAY | $4.99 4.18% 20K
|
Health Technology
|
| O: 1.6%
H: 3.03%
C: 0.9%
artificial intelligence treatment depression
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
Published: 2021-07-29 (Crawled : 04:00) - prnewswire.com
VTRS | $11.23 0.99% 1.5M
|
Health Technology
|
| O: 2.88%
H: 0.27%
C: -2.39%
diabetes treatment injection insulin approval biosimilar glargine
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.